The EvaLymph-Leg trial at a glance

December 13, 2022

A collaboration with Nij Smellinghe Hospital (the Netherlands), Hacettepe University Hospital (Turkey), Derby Hospitals NHS Foundation Trust and St-Georges University Hospital (United Kingdom)

At this moment, a screening set for patients at risk for the development of lower limb lymphedema (Aim 2), is being developed at the University Hospitals of Leuven.

Within a few weeks, we are looking for healthy volunteers (>18y) without lymphedema, willing to spend about one hour of time at the Center for Lymphoedema for a series of clinical measurements.

Are you willing to participate in scientific research and expand our knowledge?
Contact: or